AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 133.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $86.607 million which beat the analyst consensus estimate of $80.400 million by 7.72 percent. This is a 8.05 percent increase over sales of $80.158 million the same period last year.